David Olagnier

Research output

Research output per year 2007 2013 2014 2017 2019 2020 2021 2022 2023 2024 2025

• 67 Journal article
• 13 Review
• 4 Comment/debate/letter to the editor
• 2 Editorial
• 1 More
  • 1 Preprint

Research output per year

Research output per year

Search results

• 2025

  Response to the letter to editor "Clarification on Rigvir's mechanism: Interpretation of CD55 inhibition in oncolytic therapy"

  Gazal, S. & Olagnier, D., Jan 2025, In: Virology. 601, 110274.

  Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Comment/debate/letter to the editor › Research › peer-review
• 2020

  Author Correction: SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate

  Olagnier, D., Farahani, E., Thyrsted, J., Blay-Cadanet, J., Herengt, A., Idorn, M., Hait, A., Hernaez, B., Knudsen, A., Iversen, M. B., Schilling, M., Jørgensen, S. E., Thomsen, M., Reinert, L. S., Lappe, M., Hoang, H.-D., Gilchrist, V. H., Hansen, A. L., Ottosen, R. & Nielsen, C. G. & 18 others, Møller, C., van der Horst, D., Peri, S., Balachandran, S., Huang, J., Jakobsen, M., Svenningsen, E. B., Poulsen, T. B., Bartsch, L., Thielke, A. L., Luo, Y., Alain, T., Rehwinkel, J., Alcamí, A., Hiscott, J., Mogensen, T. H., Paludan, S. R. & Holm, C. K., 21 Oct 2020, In: Nature Communications. 11, 1, 1 p., 5419.

  Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Comment/debate/letter to the editor › Research › peer-review

  Open Access

  • Anti-Inflammatory Drug 100%
  • Antivirus Agent 100%
  • Severe Acute Respiratory Syndrome 100%
  • Itaconic Acid 100%
  • Fumaric Acid Dimethyl Ester 100%
  11 Citations (Scopus)

• Author Correction: STEEP mediates STING ER exit and activation of signaling (Nature Immunology, (2020), 21, 8, (868-879), 10.1038/s41590-020-0730-5)

  Zhang, B.-C., Nandakumar, R., Reinert, L. S., Huang, J., Laustsen, A., Gao, Z.-L., Sun, C.-L., Jensen, S. B., Troldborg, A., Assil, S., Berthelsen, M. F., Scavenius, C., Zhang, Y., Windross, S. J., Olagnier, D., Prabakaran, T., Bodda, C., Narita, R., Cai, Y. & Zhang, C.-G. & 11 others, Stenmark, H., Doucet, C. M., Noda, T., Guo, Z., Goldbach-Mansky, R., Hartmann, R., Chen, Z. J., Enghild, J. J., Bak, R. O., Thomsen, M. K. & Paludan, S. R., Nov 2020, In: Nature Immunology. 21, 11, p. 1468-1469 2 p.

  Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Comment/debate/letter to the editor › Research › peer-review

  • Immunology 100%
  4 Citations (Scopus)

• Oncolytic viral immunotherapy in the time of COVID-19

  Olagnier, D. & Alain, T., Dec 2020, In: Cytokine & Growth Factor Reviews. 56, December, p. 1-3 3 p.

  Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Comment/debate/letter to the editor › Research › peer-review